It would be particularly interesting to see if the conclusions drawn from the Melo or Shimokawa studies (replenishing of tumours by LGR5− cells following LGR5+ cell ablation)21,69 would be affected by the co-ablation of both LGR5+ and LGR4+ cells. The gene discussed is LGR5; the disease is neoplasm.